Oxford Immunotec Global PLC Financial Statements 2011-2024 | OXFD

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	421 M	369 M	279 M	295 M	253 M	204 M	78.8 M	-	-
Shares	-	26.6 M	26 M	23.8 M	22.4 M	21.8 M	17.3 M	3.83 M	-	-
Net Income	-	-1.81 M	121 M	-32.9 M	-22.3 M	-24.5 M	-22.2 M	-8.66 M	-14.9 M	-13.1 M
Revenue	-	73.7 M	59.8 M	103 M	86.1 M	62.8 M	49.5 M	38.8 M	20.7 M	12.6 M
EBITDA	-	-3.26 M	-16 M	-24.5 M	-22.3 M	-22 M	-20.1 M	-6.25 M	-12.1 M	-12.7 M
Operating Expenses	-	59.4 M	60.6 M	85.1 M	72 M	57.4 M	47.4 M	27.5 M	21.2 M	17.5 M
General and Administrative Expenses	-	22.3 M	26 M	30.4 M	23.2 M	16 M	14.8 M	12.1 M	8.07 M	5.23 M